China Pharma Holdings (CPHI) Buildings (2011 - 2023)

China Pharma Holdings (CPHI) has reported Buildings for 13 consecutive years, with $9.1 million the latest figure, recorded in Q2 2023.

• For the quarter ending Q2 2023, Buildings fell 7.12% year-over-year to $9.1 million; the trailing twelve-month figure through Jun 2023 stood at $9.1 million (down 7.12% YoY), and the FY2022 full-year result was $9.4 million, down 8.46% from the prior year.
• Buildings slipped to $9.1 million in Q2 2023 per CPHI's latest filing, from $9.5 million in the prior quarter.
• Across five years, Buildings topped out at $10.3 million in Q1 2022 and bottomed at $9.1 million in Q2 2023.
• Historically, Buildings has averaged $9.7 million across 5 years, with a median of $9.6 million in 2020.
• The sharpest annual moves came in 2021 and 2022: Buildings advanced 9.59% in 2021, then dropped 8.65% in 2022.
• Over 5 years, Buildings stood at $9.4 million in 2019, then increased by 6.92% to $10.0 million in 2020, then climbed by 2.34% to $10.3 million in 2021, then slipped by 8.46% to $9.4 million in 2022, then decreased by 3.61% to $9.1 million in 2023.
• According to Business Quant data, Buildings over the past three periods registered $9.1 million, $9.5 million, and $9.4 million for Q2 2023, Q1 2023, and Q4 2022 respectively.